8156 related articles for article (PubMed ID: 20795360)
1. A novel DNA vaccine constructed by heat shock protein 70 and melanoma antigen-encoding gene 3 against tumorigenesis.
Qu P; Ma JH; Zhang XM; Huang XJ; Yang XW; Yan-Fang S
Indian J Exp Biol; 2010 May; 48(5):436-43. PubMed ID: 20795360
[TBL] [Abstract][Full Text] [Related]
2. Heat shock protein 70/MAGE-3 fusion protein vaccine can enhance cellular and humoral immune responses to MAGE-3 in vivo.
Ma JH; Sui YF; Ye J; Huang YY; Li ZS; Chen GS; Qu P; Song HP; Zhang XM
Cancer Immunol Immunother; 2005 Sep; 54(9):907-14. PubMed ID: 15756604
[TBL] [Abstract][Full Text] [Related]
3. Vaccination with a DNA vaccine based on human PSCA and HSP70 adjuvant enhances the antigen-specific CD8+ T-cell response and inhibits the PSCA+ tumors growth in mice.
Zhang X; Yu C; Zhao J; Fu L; Yi S; Liu S; Yu T; Chen W
J Gene Med; 2007 Aug; 9(8):715-26. PubMed ID: 17595048
[TBL] [Abstract][Full Text] [Related]
4. A truncated C-terminal fragment of Mycobacterium tuberculosis HSP70 gene enhanced potency of HBV DNA vaccine.
Li X; Yang X; Li L; Liu H; Liu J
Vaccine; 2006 Apr; 24(16):3321-31. PubMed ID: 16472546
[TBL] [Abstract][Full Text] [Related]
5. [Construction of human MAGE-3 DNA vaccine and its immune effects observed in vivo].
Liu XE; Sun XD; Wu JM
Sheng Wu Gong Cheng Xue Bao; 2004 Mar; 20(2):165-9. PubMed ID: 15969102
[TBL] [Abstract][Full Text] [Related]
6. [Anti-tumor immune responses of nanoemulsion-encapsulated MHS vaccine].
Ge W; Sun YJ; Li Y; Zhang SH; Zhang XM; Huang Y; Hu PZ; Sui YF
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 May; 24(5):457-60. PubMed ID: 18466701
[TBL] [Abstract][Full Text] [Related]
7. Heat shock protein 70 / MAGE-1 tumor vaccine can enhance the potency of MAGE-1-specific cellular immune responses in vivo.
Ye J; Chen GS; Song HP; Li ZS; Huang YY; Qu P; Sun YJ; Zhang XM; Sui YF
Cancer Immunol Immunother; 2004 Sep; 53(9):825-34. PubMed ID: 15127237
[TBL] [Abstract][Full Text] [Related]
8. A novel vaccine strategy to induce mycobacterial antigen-specific Th1 responses by utilizing the C-terminal domain of heat shock protein 70.
Uto T; Tsujimura K; Uchijima M; Seto S; Nagata T; Suda T; Chida K; Nakamura H; Koide Y
FEMS Immunol Med Microbiol; 2011 Mar; 61(2):189-96. PubMed ID: 21204994
[TBL] [Abstract][Full Text] [Related]
9. Targeted immunotherapy using reconstituted chaperone complexes of heat shock protein 110 and melanoma-associated antigen gp100.
Wang XY; Chen X; Manjili MH; Repasky E; Henderson R; Subjeck JR
Cancer Res; 2003 May; 63(10):2553-60. PubMed ID: 12750279
[TBL] [Abstract][Full Text] [Related]
10. Modified HPV16 E7/HSP70 DNA vaccine with high safety and enhanced cellular immunity represses murine lung metastatic tumors with downregulated expression of MHC class I molecules.
Li H; Ou X; Xiong J
Gynecol Oncol; 2007 Mar; 104(3):564-71. PubMed ID: 17081598
[TBL] [Abstract][Full Text] [Related]
11. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene.
Chen CH; Wang TL; Hung CF; Yang Y; Young RA; Pardoll DM; Wu TC
Cancer Res; 2000 Feb; 60(4):1035-42. PubMed ID: 10706121
[TBL] [Abstract][Full Text] [Related]
13. Development of a novel Hsp70-based DNA vaccine as a multifunctional antigen delivery system.
Yamaoka A; Guan X; Takemoto S; Nishikawa M; Takakura Y
J Control Release; 2010 Mar; 142(3):411-5. PubMed ID: 19913062
[TBL] [Abstract][Full Text] [Related]
14. The treatment and prevention of mouse melanoma with an oral DNA vaccine carried by attenuated Salmonella typhimurium.
Zhu X; Cai J; Huang J; Jiang X; Ren D
J Immunother; 2010 Jun; 33(5):453-60. PubMed ID: 20463603
[TBL] [Abstract][Full Text] [Related]
15. Generation of anti-tumor immunity using mammalian heat shock protein 70 DNA vaccines for cancer immunotherapy.
Li Y; Subjeck J; Yang G; Repasky E; Wang XY
Vaccine; 2006 Jun; 24(25):5360-70. PubMed ID: 16714072
[TBL] [Abstract][Full Text] [Related]
16. MAGE-1/Heat shock protein 70/MAGE-3 fusion protein vaccine in nanoemulsion enhances cellular and humoral immune responses to MAGE-1 or MAGE-3 in vivo.
Ge W; Sui YF; Wu DC; Sun YJ; Chen GS; Li ZS; Si SY; Hu PZ; Huang Y; Zhang XM
Cancer Immunol Immunother; 2006 Jul; 55(7):841-9. PubMed ID: 16155756
[No Abstract] [Full Text] [Related]
17. A novel chimeric DNA vaccine: enhancement of preventive and therapeutic efficacy of DNA vaccine by fusion of Mucin 1 to a heat shock protein 70 gene.
Choi DH; Woo JK; Choi Y; Seo HS; Kim CW
Mol Med Rep; 2011; 4(5):885-90. PubMed ID: 21725596
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic efficacy of a tuberculosis DNA vaccine encoding heat shock protein 65 of Mycobacterium tuberculosis and the human interleukin 2 fusion gene.
Changhong S; Hai Z; Limei W; Jiaze A; Li X; Tingfen Z; Zhikai X; Yong Z
Tuberculosis (Edinb); 2009 Jan; 89(1):54-61. PubMed ID: 19056317
[TBL] [Abstract][Full Text] [Related]
19. Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice.
Karan D; Dubey S; Van Veldhuizen P; Holzbeierlein JM; Tawfik O; Thrasher JB
Immunotherapy; 2011 Jun; 3(6):735-46. PubMed ID: 21668311
[TBL] [Abstract][Full Text] [Related]
20. Prevention of metastases with a Mage-b DNA vaccine in a mouse breast tumor model: potential for breast cancer therapy.
Sypniewska RK; Hoflack L; Tarango M; Gauntt S; Leal BZ; Reddick RL; Gravekamp C
Breast Cancer Res Treat; 2005 May; 91(1):19-28. PubMed ID: 15868428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
